Christine M. Freitag, Wolfgang Retz: ADHS und komorbide Erkrankungen: neurobiologische Grundlagen und diagnostisch-therapeutische Praxis bei Kindern und Erwachsenen. W. Kohlhammer Verlag, 2007, ISBN 978-3-17-019081-8, S.81 (google.com).
M. Teitler, N. Toohey, J. A. Knight, M. T. Klein, C. Smith: Clozapine and other competitive antagonists reactivate risperidone-inactivated h5-HT7 receptors: radioligand binding and functional evidence for GPCR homodimer protomer interactions. In: Psychopharmacology, Band 212, Nummer 4, Dezember 2010, S. 687–697, doi:10.1007/s00213-010-2001-x, PMID 20827463, PMC 3052287 (freier Volltext).
Andrew A. Nierenberg, Michael J. Ostacher, Joseph R. Calabrese, Terence A. Ketter, Lauren B. Marangell, David J. Miklowitz, Sachiko Miyahara, Mark S. Bauer, Michael E. Thase, Stephen R. Wisniewski, Gary S. Sachs, STEP-BD Investigators: Treatment-Resistant Bipolar Depression: A STEP-BD Equipoise Randomized Effectiveness Trial of Antidepressant Augmentation With Lamotrigine, Inositol, or Risperidone. In: American Journal of Psychiatry. Band163, Nr.2, Februar 2006, S.210–216, doi:10.1176/appi.ajp.163.2.210, PMID 16449473.
W. G. Honer, A. E. Thornton, E. Y. Chen, R. C. Chan, J. O. Wong, A. Bergmann, P. Falkai, E. Pomarol-Clotet, P. J. McKenna, E. Stip, R. Williams, G. W. MacEwan, K. Wasan, R. Procyshyn; Clozapine and Risperidone Enhancement (CARE) Study Group: Clozapine Alone versus Clozapine and Risperidone with Refractory Schizophrenia. In: New England Journal of Medicine, 354(5), 2. Februar 2006, S. 472–482. PMID 16452559.
nih.gov
ncbi.nlm.nih.gov
J. G. Csernansky u. a.: A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. In: New England Journal of Medicine. 346(1), 3. Jan 2002, S. 16–22. PMID 11777998.
J. A. Lieberman u. a.: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. In: New England Journal of Medicine. 353(12), 22. Sep 2005, S. 1209–1223. PMID 16172203.
A. Schotte, P. F. M. Janssen, W. Gommeren: Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. In: Psychpharmacol. 124, 1996, S. 57–73. PMID 8935801.
M. Teitler, N. Toohey, J. A. Knight, M. T. Klein, C. Smith: Clozapine and other competitive antagonists reactivate risperidone-inactivated h5-HT7 receptors: radioligand binding and functional evidence for GPCR homodimer protomer interactions. In: Psychopharmacology, Band 212, Nummer 4, Dezember 2010, S. 687–697, doi:10.1007/s00213-010-2001-x, PMID 20827463, PMC 3052287 (freier Volltext).
Häufigkeit von Rigor unter Flupentixoldecanoat und Risperidon in Abhängigkeit von der Dosierung. In: Psychiatr Prax., 31 Suppl 1, Nov 2004, S. 167–169. PMID 15570542.
Andrew A. Nierenberg, Michael J. Ostacher, Joseph R. Calabrese, Terence A. Ketter, Lauren B. Marangell, David J. Miklowitz, Sachiko Miyahara, Mark S. Bauer, Michael E. Thase, Stephen R. Wisniewski, Gary S. Sachs, STEP-BD Investigators: Treatment-Resistant Bipolar Depression: A STEP-BD Equipoise Randomized Effectiveness Trial of Antidepressant Augmentation With Lamotrigine, Inositol, or Risperidone. In: American Journal of Psychiatry. Band163, Nr.2, Februar 2006, S.210–216, doi:10.1176/appi.ajp.163.2.210, PMID 16449473.
H. Fukui, T. Murai: Severe Weight Gain Induced by Combination Treatment With Risperidone and Paroxetine. In: Clin Neuropharmacol., 25, 2002, S. 269–271. PMID 12410060.
W. G. Honer, A. E. Thornton, E. Y. Chen, R. C. Chan, J. O. Wong, A. Bergmann, P. Falkai, E. Pomarol-Clotet, P. J. McKenna, E. Stip, R. Williams, G. W. MacEwan, K. Wasan, R. Procyshyn; Clozapine and Risperidone Enhancement (CARE) Study Group: Clozapine Alone versus Clozapine and Risperidone with Refractory Schizophrenia. In: New England Journal of Medicine, 354(5), 2. Februar 2006, S. 472–482. PMID 16452559.
H. J. Möller u. a.: Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia. In: Int J Neuropsychopharmacol. 11 (7), 2008, S. 985–997. PMID 18466670.
Edward P. Monnelly, Domenic A. Ciraulo, Clifford Knapp, Terence Keane: Low-Dose Risperidone as Adjunctive Therapy for Irritable Aggression in Posttraumatic Stress Disorder. In: Journal of Clinical Psychopharmacology, 23, April 2003, S. 193–196. (Abstract)